Hydrochloric Acid → HCID 118364779, compound
Reaction equation
C[N:2]1[CH2:7][CH:6]=[C:5]([C:8]2[CH:9]=[N:10][C:11]([N:14]3[CH2:19][CH2:18][CH2:17][CH:16]([CH2:20][N:21]4[C:25]5=[N:26][C:27]([C:30]6[CH:31]=[N:32][N:33]([CH3:35])[CH:34]=6)=[CH:28][N:29]=[C:24]5[N:23]=[N:22]4)[CH2:15]3)=[N:12][CH:13]=2)[CH2:4][CH2:3]1.[ClH:36]>C(Cl)Cl.O1CCOCC1>[ClH:36].[CH3:35][N:33]1[CH:34]=[C:30]([C:27]2[N:26]=[C:25]3[N:21]([CH2:20][CH:16]4[CH2:17][CH2:18][CH2:19][N:14]([C:11]5[N:12]=[CH:13][C:8]([C:5]6[CH2:6][CH2:7][NH:2][CH2:3][CH:4]=6)=[CH:9][N:10]=5)[CH2:15]4)[N:22]=[N:23][C:24]3=[N:29][CH:28]=2)[CH:31]=[N:32]1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
1-((1-(5-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)pyrimidin-2-yl)piperidin-3-yl)methyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (125 mg, 0.22 mmol) was dissolved in CH2Cl2 (5 ml), and then 4 N HCl dissolved in dioxane (1 ml) was added, followed by stirring at room temperature. After the reaction was completed, the reaction mixture was concentrated under reduced pressure, and then purified with ether, to give 6-(1-methyl-1H-pyrazol-4-yl)-1-((1-(5-(1,2,3,6-tetrahydropyridin-4-yl)pyrimidin-2-yl)piperidin-3-yl)methyl)-1H-[1,2,3]triazolo[4,5-b]pyrazine hydrochloride (90 mg, 82%).
Workup
- additionwas added
- concentrationthe reaction mixture was concentrated under reduced pressure
- custompurified with ether
Sources & evidence
- ORD record
- ord-0c0a6c85cbae4740a58a21325cd53055
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09403831B2
Reaction notes
Loading…